Amicus Therapeutics, Inc
N/A
USD
N/A
N/A
...
Chart
Financials
Description
FOLD Company Description
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
FOLD Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view FOLD Smart Score
Score Breakdown
FOLD Company Description
Show More
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of FOLD by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by FOLD's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on FOLD's company Twitter account
WallStreetBets
Number of mentions of FOLD in WallStreetBets Daily Discussion
FOLD News
Recent insights relating to FOLD
CNBC Recommendations
Recent picks made for FOLD stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in FOLD
Corporate Flights
Flights by private jets registered to FOLD
Our Analysis